Latest Progressive Supranuclear Palsy Stories
The second most common cause of degenerative Parkinsonism is a devastating disease that currently has no available treatment.
An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications.
There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a new study from an international genetics team led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
TIMONIUM, Md., June 19, 2011 /PRNewswire/ -- An international team of researchers led by Gerard D.
MADISON, Wis., May 9, 2011 /PRNewswire/ -- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System (CNS) disorders, announces that the U.S.
- A poem in which the author retracts something said in an earlier poem.